Shouhui Group Limited (Stock Code: 2621) Annual Report 2025: Comprehensive Investor Analysis

Executive Summary

Shouhui Group Limited, a leading life and health insurance intermediary service provider in China, has released its Annual Report for 2025. The document presents a detailed overview of the company’s financial performance, strategic developments, and future outlook. Several notable points have emerged which could be significant for shareholders and may impact the company’s share value.

1. Financial Performance Highlights

• Revenue Growth: The Group achieved a revenue of RMB 1,469.2 million in 2025, representing a 5.9% year-on-year increase from RMB 1,387.1 million in 2024.
• Profit Recovery: The profit for the year surged to RMB 793.6 million, a dramatic turnaround from a loss of RMB 135.6 million in 2024, mainly due to a gain from the remeasurement of financial instruments issued to investors.
• Adjusted Profit: Adjusted profit (non-HKFRS measure) was RMB 200.2 million, a decrease of 17.1% year-on-year, reflecting a normalization of recurring operations post-listing.
• Dividend Announcement: The Board recommended a final dividend of HK\$0.14 per share (tax inclusive), pending shareholder approval. The total payout will depend on the number of shares not held as treasury shares on the record date.

2. Strategic and Business Developments

• Product Innovation and Brand Expansion:
  • Continuous iteration and enrichment of product portfolios including critical illness, whole life, pension annuity, and casualty insurance.
  • Focus on customized, high-quality participating (dividend) insurance products in partnership with top insurers, aiming to boost brand recognition and market competitiveness.
• Corporate Client Focus:
  • Expansion of insurance solutions for corporate clients using three main platforms: Xiaoyusan, Kachabao, and Niubao 100, to build a comprehensive ecosystem covering both individual and corporate needs.
• Distribution Channel Enhancement:
  • Strengthening both online and offline integrated marketing strategies, deepening branch network, and recruiting productive agents.
  • Active collaboration with media, KOLs, agencies, and brokerages to form high-performing alliances and enhance the reach of customized products.
• Technology and R&D Investment:
  • Continued investment in digital tools, online transaction systems, intelligent marketing, and AI applications to empower business growth and improve operational efficiency.
• Material Investments:
  • Significant investments in negotiable certificates of deposit and wealth management products, with substantial holdings in SPDB and related entities, constituting 6.2% of total assets.
• Acquisition Post-Reporting Period:
  • In January 2026, the Group acquired 35.25% of Health Vision Hong Kong Limited for HKD 15.5 million, potentially opening new business avenues in health-related services.

3. Capital Structure and Corporate Actions

• IPO and Share Issuance:
  • Successful Main Board listing on May 30, 2025, raising net proceeds of HK\$134.2 million. As of December 31, 2025, HK\$15.1 million had been used, predominantly for sales network expansion, marketing, and tech infrastructure, with the remainder reserved for future deployment by 2029.
• Share Buyback and Treasury Shares:
  • 246,400 shares repurchased in December 2025, now held as treasury shares. This could affect the total dividend payout and EPS calculations.
• Conversion of Preferred Shares:
  • All preferred shares converted to ordinary shares upon IPO, resulting in a one-off gain of RMB 619 million from the remeasurement of financial instruments previously recognized as liabilities.
• Dividend Policy:
  • No formal dividend policy; future dividends will depend on profitability, capital needs, and board discretion, with 2025’s proposed final dividend being subject to approval at the June 2026 AGM.

4. Corporate Governance and Risk Management

• Governance Structure:
  • Board composed of executive, non-executive, and independent non-executive directors. Chairman and CEO roles are both held by Mr. Yao Guang, a deviation from the Corporate Governance Code, but justified by the Board’s collective experience and oversight.
• Risk Controls:
  • Comprehensive risk management and internal control systems in place, with regular audits, compliance training, and board-level oversight of contractually sensitive arrangements, particularly those relating to the company’s VIE structure and continuing connected transactions.
• Compliance:
  • The company confirms full compliance with Listing Rules, including disclosure of related-party transactions and observance of minimum public float requirements since listing.

5. Key Shareholder and Insider Information

• Top Shareholders:
  • Mr. Yao Guang (Chairman/CEO) controls 47.64% of the company via Little Green Light Ltd and Little Blue Light Ltd. Other significant blocks are held by Gopher SPV, Tibet Juzhi, HongShan Yucheng, and others.
  • No director or controlling shareholder is engaged in competing business or has material conflicts of interest.
• Employee Incentives:
  • Pre-IPO Share Award Scheme in place, with awards vesting over a multi-year schedule to retain talent and incentivize performance.

6. Risks and Unusual Items

• Revenue Concentration:
  • Five largest customers account for 69.3% of total sales, indicating a concentration risk.
• No Bank Borrowings:
  • No outstanding bank loans or debentures as of year-end 2025, reflecting a conservative capital structure but also limiting leverage-driven growth.
• Regulatory and VIE Risks:
  • The company operates via VIE (Contractual Arrangement) structures with annual review and monitoring, subject to future regulatory changes in China, which could materially impact group operations and investor rights.

7. Outlook and Investor Considerations

• Growth Strategy:
  • Focus on product innovation, digital transformation, and expanding both individual and corporate client bases through technology and distribution partnerships.
• Use of IPO Proceeds:
  • Substantial IPO capital remains to be deployed, offering further capacity for expansion, M&A, and technology investment as planned through 2029.
• Potential Catalysts:
  • Material investments, technology upgrades, and the post-period acquisition could provide positive momentum, but investors should also monitor for execution risks and any regulatory updates affecting VIE structures.

Conclusion

Shouhui Group Limited’s 2025 Annual Report reveals a company in transition, successfully completing its IPO, returning to profitability, and positioning itself for future growth through innovation, technology, and disciplined capital management. The proposed dividend, substantial cash reserves, and post-period acquisition are all potential price-sensitive events. Investors should closely monitor AGMs, dividend record dates, and any regulatory changes impacting VIE structures or the insurance sector overall for further catalysts or risks.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a professional advisor before making any investment decisions. The author and publisher accept no liability for any actions taken based on this information.

View SHOUHUI GROUP Historical chart here